Recent data have shown that in ALS patients with high levels of cytoplasmic phosphorylated TDP‐43, myelin genes were downregulated as a direct consequence (Wang et al. 2025); however, perhaps upregulating promyelinating pathways can provide a therapeutic avenue. Here, TARDBP is linked to amyotrophic lateral sclerosis.